Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 8

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  naltrexone
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
Background: Rats with liver cirrhosis, evoked by chronic administration of thioacetamide (TAA), consumed voluntarily more alcohol than their healthy counterparts. Seeking the mechanisms underlying this phenomenon, the opioid system was screened for involvement and alterations. In vivo, the influence of chronically administered Naloxone and Naltrexone, non-specific opioid receptor antagonists, on alcohol intake was examined in free choice tests between 10% alcohol and tap water and ex vivo receptor binding studies were performed on cerebral membrane preparations. Methods: TAA rats, selected for the study, had confirmed liver insufficiency: their plasma bilirubin concentrations were about 3 times higher, the prothrombin time was 50% longer and they consumed voluntarily 3 times more alcohol than the control animals. The drugs were given s.c. for five days, at the beginning of the dark phase of a 24h cycle, in a daily dose of 10 mg per kg body mass. Throughout the treatment, the rats were kept individually in metabolic cages with a free access to water, alcohol solution and food. Feed and fluid consumption, as well as the urine outputs, were recorded on the 2h, 4h, 6h and 24h after the drug administration. The mu opioid ligand – [3H]-(D-Ala2, -N-MePhe4, Glyol5) Enkephalin was used to obtain binding characteristics of the control and TAA rat brain membranes. Results: The drugs, if modified drinking behaviours, they did it transiently; alcohol, water and thus the total fluid intake by the cirrhotic and control rats was significantly less after 2h – 6h from either naloxone or naltrexone administration. Both drugs decreased general fluid consumption as such rather than the consumption of alcohol only, as observed from the recordings related to TAA rats. The binding data: Kd of 2.62 ± 0.98 nM and Bmax of 43.71 ± 6.12 fmol/mg protein for cirrhotic rats, versus Kd of 4.63 ± 1.98 nM and Bmax 95.61 ± 18.33 fmol/mg protein for the control ones, suggest that while the affinity of radioligand to cerebral mu receptors was similar for the two groups, there was a lower density of those receptors in the cirrhotic rats. Conclusions: The results indicate some disturbances in the opioid system in cirrhotic rats. However, the low response to opioid therapy suggests that the opioid system may have only be partly involved in the development of the observed increased alcohol drinking in the rats with liver cirrhosis.
Hypoxia experienced by the fetus is beli ved to be a major cause of disturbed CNS function during childhood. During perinatal hypoxia endogenous opioids are released in large amounts and the developing brain in the last week of gestation may be influenced by circulating opioids, down-regulates n-opioid receptors in neonatal brain. The opioid antagonist, Naltrexone (N) blocks opiate receptors in the brain after chronic administration and can result in either up- or down-regulation of opioid receptors in the brain structures. To test the hypothesis that Naltrexone prevents prenatal chronic hypoxia-induced changes in (i-opioid receptor system in developing brain, we quantified optical density of the (i-opioid receptors in several areas of newborn rat brain. In CPu and ZG cerebral structures of rats long-lasting anoxia leads to the decrease in optical density of ^-opioid receptors. Naltrexone prevents optical density of ^-opioid receptors in CPu, OT, MMPoA and LMPoA structures from decreasing.
Background. Ghrelin, a newly discovered hormone is involved mainly in the regulation of body energy homeostasis. It has also been proved that ghrelin affects many other processes including the control of the hypothalamo-pituitary-gonadal axis in vertebrates. Ghrelin interacts also with other peptides and neurotransmitters, which are involved in gonadotropin release, such as endogenous opioid peptides. The aim of the experiment was to compare the effects of ghrelin and naltrexone, an opioid antagonist, on LH secretion by pituitary cells of mature female and male common carp, Cyprinus carpio L. Materials and methods. In the in vitro experiment the time-dependent (10 and 24 h) action of ghrelin (10-7 or 10-6 M) and naltrexone at 10-6 M added alone or in combination on LH secretion by enzymatically dispersed pituitary cells of mature female and male carp (Cyprinus carpio L.) was studied. Results. Ghrelin alone at a dose of 10-6 M stimulated LH secretion after 10 h of female- but not male-derived cell incubations. Ghrelin at 10-7 M had no effect on LH secretion from either female or male cells. Naltrexone alone stimulated LH secretion only after 24 h of female cell culture. In male cells no significant changes in LH secretion in response to naltrexone alone were found after 10 or 24 h incubation period. Combined treatment (ghrelin 10-7 or 10-6 M and naltrexone) stimulated LH secretion in female and male cell incubations at 10 and 24 h: LH levels were significantly higher in comparison to control, to ghrelin alone (in cells of both sexes) and to naltrexone alone (in male cells only). Conclusion. The results suggest that opioids and ghrelin may control LH secretion in carp acting synergistically, probably through the same receptor type. The concept of opioid and ghrelin interaction in the gonadal steroid feedback on LH release is also discussed.
The effects of naltrexone on the in vitro luteinizing hormone (LH) secretion from whole pituitary glands as well as from dispersed pituitary cells of common carp (Cyprinus carpio L.)in primary cell culture were studied. The perifusion of whole pituitary glands with naltrexone at a concentration of 10⁻⁴ M caused a significant increase of LH secretion compared to the control. This finding suggests that opioid peptides can indirectly affect LH secretion at the pituitary level, probably through the nerve terminals containing GnRH and/or DA present in the pituitary. In the perifusion of dispersed pituitary cells with naltrexone at concentrations of 10⁻⁶ or 10⁻⁴ M, significant increases of LH levels were found. Similar results were observed in static culture of dispersed carp pituitary cells: after 4 or 24 hours of culture in the medium containing naltrexone at concentrations of 10⁻⁶, 10⁻⁴ or 10⁻² M,a dose-dependent, statistically significant increase of LH secretion to the culture medium was found. The results from dispersed pituitary cell perifusions or cell culture with naltrexone indicate that this antagonist directly affects the pituitary cells and stimulates LH release from carp gonadotrophs.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.